Connect with us

Business

Telix (ASX:TLX) share price lower despite key FDA update

Published

on

Image source: Getty Images

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is edging lower on Thursday morning despite the release of a positive announcement.

At the time of writing, the biopharmaceuticals company’s shares are down slightly to $5.61.

What did Telix…



Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending